NEONATAL HEPATOMEGALY

This adverse event was reported 56 times

These drugs are most commonly taken by patients reporting NEONATAL HEPATOMEGALY:

# Drug Count
0 VENLAFAXINE 9
1 VENLAFAXINE HYDROCHLORIDE 9
2 ZIDOVUDINE 8
3 CEFIXIME 7
4 DARIDOREXANT 7
5 FERROUS SULFATE 7
6 OLANZAPINE 7
7 FLUTICASONE PROPIONATE 6
8 FLUTICASONE PROPIONATE NASAL 6
9 IMMUNE GLOBULIN 5
See all common drugs associated with NEONATAL HEPATOMEGALY

NEONATAL HEPATOMEGALY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DARIDOREXANT 7 0.0025
1 NELFINAVIR MESYLATE 5 0.0024
2 CEFIXIME 7 0.0023
3 PORACTANT ALFA 1 0.0014
4 ZINC SULFATE INJECTION, 3 0.0010
5 ZINC SULFATE INJECTION 3 0.0010
6 SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE 1 0.0010
7 ZIDOVUDINE 8 0.0008
8 CLOMIPRAMINE HYDROCHLORIDE 2 0.0004
9 LAMIVUDINE AND ZIDOVUDINE 3 0.0004
See all drugs enriched for association with NEONATAL HEPATOMEGALY